These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

710 related articles for article (PubMed ID: 19626608)

  • 21. Early findings of oseltamivir-resistant pandemic (H1N1) 2009 influenza A viruses in Taiwan.
    Yang JR; Huang YP; Lin YC; Su CH; Kuo CY; Hsu LC; Wu HS; Liu MT
    Antiviral Res; 2010 Dec; 88(3):256-62. PubMed ID: 20869989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First case in Italy of acquired resistance to oseltamivir in an immunocompromised patient with influenza A/H1N1v infection.
    Campanini G; Piralla A; Rovida F; Puzelli S; Facchini M; Locatelli F; Minoli L; Percivalle E; Donatelli I; Baldanti F;
    J Clin Virol; 2010 Jul; 48(3):220-2. PubMed ID: 20447860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007.
    Tashiro M; McKimm-Breschkin JL; Saito T; Klimov A; Macken C; Zambon M; Hayden FG;
    Antivir Ther; 2009; 14(6):751-61. PubMed ID: 19812437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of antiviral resistance and genetic lineage markers in influenza B virus neuraminidase using pyrosequencing.
    Sheu TG; Deyde VM; Garten RJ; Klimov AI; Gubareva LV
    Antiviral Res; 2010 Feb; 85(2):354-60. PubMed ID: 19887086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic diversity and antiviral drug resistance of pandemic H1N1 2009 in Lebanon.
    Zaraket H; Kondo H; Tabet C; Hanna-Wakim R; Suzuki Y; Dbaibo GS; Saito R; Suzuki H
    J Clin Virol; 2011 Jul; 51(3):170-4. PubMed ID: 21565547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
    Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
    Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses.
    Baz M; Abed Y; Simon P; Hamelin ME; Boivin G
    J Infect Dis; 2010 Mar; 201(5):740-5. PubMed ID: 20100088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different neuraminidase inhibitor susceptibilities of human H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany from 2001 to 2005/2006.
    Bauer K; Richter M; Wutzler P; Schmidtke M
    Antiviral Res; 2009 Apr; 82(1):34-41. PubMed ID: 19428593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(35):969-72. PubMed ID: 19745803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pacific region influenza surveillance for oseltamivir resistance.
    Miller HB; Gose RB; Nagata MT; Sciulli RH; Whelen AC
    J Clin Virol; 2012 May; 54(1):73-5. PubMed ID: 22296793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simplified screening method for detecting oseltamivir resistant pandemic influenza A (H1N1) 2009 virus by a RT-PCR/restriction fragment length polymorphism assay.
    Nukiwa N; Suzuki A; Furuse Y; Shimabukuro K; Odagiri T; Khandaker I; Oshitani H
    J Virol Methods; 2010 Dec; 170(1-2):165-8. PubMed ID: 20833206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuraminidase-inhibitor resistance testing for pandemic influenza A (H1N1) 2009 in Ontario, Canada.
    Longtin J; Patel S; Eshaghi A; Lombos E; Higgins R; Alexander D; Olsha R; Doyle J; Tran D; Sarabia A; Lee C; Bastien N; Li Y; Low D; Boivin G; Gubbay J
    J Clin Virol; 2011 Mar; 50(3):257-61. PubMed ID: 21251873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oseltamivir-resistant influenza viruses isolated in South Korea from 2005 to 2010.
    Cho HG; Choi JH; Lee HK; Mun SK; Lee JB; Jho EH; Kang C; Lim YH
    Arch Virol; 2013 Nov; 158(11):2365-70. PubMed ID: 23690054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of pyrosequencing and neuraminidase inhibition assays for the detection of oseltamivir-resistant pandemic influenza A(H1N1) 2009 viruses.
    Deng YM; Caldwell N; Hurt A; Shaw T; Kelso A; Chidlow G; Williams S; Smith D; Barr I
    Antiviral Res; 2011 Apr; 90(1):87-91. PubMed ID: 21376084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010.
    Hurt AC; Deng YM; Ernest J; Caldwell N; Leang L; Iannello P; Komadina N; Shaw R; Smith D; Dwyer DE; Tramontana AR; Lin RT; Freeman K; Kelso A; Barr IG
    Euro Surveill; 2011 Jan; 16(3):. PubMed ID: 21262183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.
    Meijer A; Jonges M; Abbink F; Ang W; van Beek J; Beersma M; Bloembergen P; Boucher C; Claas E; Donker G; van Gageldonk-Lafeber R; Isken L; de Jong A; Kroes A; Leenders S; van der Lubben M; Mascini E; Niesters B; Oosterheert JJ; Osterhaus A; Riesmeijer R; Riezebos-Brilman A; Schutten M; Sebens F; Stelma F; Swaan C; Timen A; van 't Veen A; van der Vries E; te Wierik M; Koopmans M
    Antiviral Res; 2011 Oct; 92(1):81-9. PubMed ID: 21767571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro.
    Gubareva LV; Trujillo AA; Okomo-Adhiambo M; Mishin VP; Deyde VM; Sleeman K; Nguyen HT; Sheu TG; Garten RJ; Shaw MW; Fry AM; Klimov AI
    Antivir Ther; 2010; 15(8):1151-9. PubMed ID: 21149922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring of the h275y mutation in pandemic influenza A(H1N1) 2009 strains isolated in Malaysia.
    Suppiah J; Yusof MA; Othman KA; Saraswathy TS; Thayan R; Kasim FM; Murad S; Saat Z
    Southeast Asian J Trop Med Public Health; 2011 Jan; 42(1):100-4. PubMed ID: 21323171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model.
    Hurt AC; Lowther S; Middleton D; Barr IG
    Antiviral Res; 2010 Sep; 87(3):361-6. PubMed ID: 20603155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amantadine- and oseltamivir-resistant variants of influenza A viruses in Thailand.
    Bai GR; Chittaganpitch M; Kanai Y; Li YG; Auwanit W; Ikuta K; Sawanpanyalert P
    Biochem Biophys Res Commun; 2009 Dec; 390(3):897-901. PubMed ID: 19850010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.